Risk Management (Nano-Governance)

Risk assessment of Nanobiotechnology is an important part of the development of new Nanobiotechnology and products. Nanobiotechnology are materials with at least one dimension in the nanoscale range (1–100 nm). These materials have unique properties that make them attractive for use in industrial and consumer products. However, the unique properties of Nanobiotechnology may also present health and environmental risks, so risk assessment is essential for ensuring their safe use. Risk assessment of Nanobiotechnology is a multidisciplinary process that involves gathering and analyzing data from toxicology, toxicokinetics, and exposure studies. Data from these studies is used to estimate the potential risks posed by a nanomaterial. This process typically begins with a hazard assessment, which involves identifying the potential adverse effects of a nanomaterial. Next, a risk characterization evaluates the likelihood that a nanomaterial will cause harm and estimates the magnitude of the risk. Finally, a risk management plan is developed to reduce or eliminate the identified risks. Risk assessment is an ongoing process that is conducted throughout the product development process.